Literature DB >> 17596301

Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.

Matthew Frieman1, Boyd Yount, Mark Heise, Sarah A Kopecky-Bromberg, Peter Palese, Ralph S Baric.   

Abstract

The host innate immune response is an important deterrent of severe viral infection in humans and animals. Nuclear import factors function as key gatekeepers that regulate the transport of innate immune regulatory cargo to the nucleus of cells to activate the antiviral response. Using severe acute respiratory syndrome coronavirus (SARS-CoV) as a model, we demonstrate that SARS-COV ORF6 protein is localized to the endoplasmic reticulum (ER)/Golgi membrane in infected cells, where it binds to and disrupts nuclear import complex formation by tethering karyopherin alpha 2 and karyopherin beta 1 to the membrane. Retention of import factors at the ER/Golgi membrane leads to a loss of STAT1 transport into the nucleus in response to interferon signaling, thus blocking the expression of STAT1-activated genes that establish an antiviral state. We mapped the region of ORF6, which binds karyopherin alpha 2, to the C terminus of ORF6 and show that mutations in the C terminus no longer bind karyopherin alpha 2 or block the nuclear import of STAT1. We also show that N-terminal deletions of karyopherin alpha 2 that no longer bind to karyopherin beta 1 still retain ORF6 binding activity but no longer block STAT1 nuclear import. Recombinant SARS-CoV lacking ORF6 did not tether karyopherin alpha 2 to the ER/Golgi membrane and allowed the import of the STAT1 complex into the nucleus. We discuss the likely implications of these data on SARS-CoV replication and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596301      PMCID: PMC2045396          DOI: 10.1128/JVI.01012-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Structure of importin-beta bound to the IBB domain of importin-alpha.

Authors:  G Cingolani; C Petosa; K Weis; C W Müller
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

2.  Capturing protein interactions in the secretory pathway of living cells.

Authors:  Beat Nyfeler; Stephen W Michnick; Hans-Peter Hauri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

3.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 4.  Transport routes through the nuclear pore complex.

Authors:  L F Pemberton; G Blobel; J S Rosenblum
Journal:  Curr Opin Cell Biol       Date:  1998-06       Impact factor: 8.382

5.  Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences.

Authors:  S G Nadler; D Tritschler; O K Haffar; J Blake; A G Bruce; J S Cleaveland
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.

Authors:  Martin Spiegel; Andreas Pichlmair; Luis Martínez-Sobrido; Jerome Cros; Adolfo García-Sastre; Otto Haller; Friedemann Weber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Identification of a novel coronavirus in bats.

Authors:  L L M Poon; D K W Chu; K H Chan; O K Wong; T M Ellis; Y H C Leung; S K P Lau; P C Y Woo; K Y Suen; K Y Yuen; Y Guan; J S M Peiris
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Authors:  J P Parisien; J F Lau; J J Rodriguez; B M Sullivan; A Moscona; G D Parks; R A Lamb; C M Horvath
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

9.  A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus.

Authors:  Lecia Pewe; Haixia Zhou; Jason Netland; Chandra Tangudu; Heidi Olivares; Lei Shi; Dwight Look; Thomas Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  The severe acute respiratory syndrome coronavirus 3a is a novel structural protein.

Authors:  Shuo Shen; Pi-Shiu Lin; Yu-Chan Chao; Aihua Zhang; Xiaoming Yang; Seng Gee Lim; Wanjin Hong; Yee-Joo Tan
Journal:  Biochem Biophys Res Commun       Date:  2005-04-29       Impact factor: 3.575

View more
  273 in total

1.  Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist.

Authors:  Daniela Niemeyer; Thomas Zillinger; Doreen Muth; Florian Zielecki; Gabor Horvath; Tasnim Suliman; Winfried Barchet; Friedemann Weber; Christian Drosten; Marcel A Müller
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 2.  Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.

Authors:  Matthew Frieman; Ralph Baric
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

3.  Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor.

Authors:  Weijia Cheng; Shiyou Chen; Ruiling Li; Yu Chen; Min Wang; Deyin Guo
Journal:  Virol Sin       Date:  2015-04-17       Impact factor: 4.327

4.  A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.

Authors:  Adriaan H de Wilde; Kazimier F Wannee; Florine E M Scholte; Jelle J Goeman; Peter Ten Dijke; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.

Authors:  Mathieu Mateo; St Patrick Reid; Lawrence W Leung; Christopher F Basler; Viktor E Volchkov
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

6.  3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.

Authors:  Yijun Du; Jingshan Bi; Jiyu Liu; Xing Liu; Xiangju Wu; Ping Jiang; Dongwan Yoo; Yongguang Zhang; Jiaqiang Wu; Renzhong Wan; Xiaomin Zhao; Lihui Guo; Wenbo Sun; Xiaoyan Cong; Lei Chen; Jinbao Wang
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Systematic assembly of a full-length infectious clone of human coronavirus NL63.

Authors:  Eric F Donaldson; Boyd Yount; Amy C Sims; Susan Burkett; Raymond J Pickles; Ralph S Baric
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

Review 8.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

9.  Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo.

Authors:  Susanne Pfefferle; Verena Krähling; Vanessa Ditt; Klaus Grywna; Elke Mühlberger; Christian Drosten
Journal:  Virol J       Date:  2009-08-24       Impact factor: 4.099

10.  Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex.

Authors:  Kam-Leung Siu; Kin-Hang Kok; Ming-Him James Ng; Vincent K M Poon; Kwok-Yung Yuen; Bo-Jian Zheng; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.